Current status and challenges of gastrointestinal cancer treatment in China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Current status and challenges of gastrointestinal cancer treatment in China

Published:2023-10-03 Issue:11 Volume:153 Page:1875-1876
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Shen Lin¹

Affiliation:

1. State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research Gastrointestinal Oncology, Department of Gastrointestinal Oncology and Phase I Clinical Trial Center Peking University Cancer Hospital & Institute Beijing China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.34729

Reference4 articles.

1. Cancer incidence and mortality in China, 2016

2. Anticancer drug R&D of gastrointestinal cancer in China: current landscape and challenges;Shen L;Innovations,2022

3. Efficacy and safety of a novel anti‐HER2 therapeutic antibody RC48 in patients with HER2‐overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single‐arm phase II study

4. Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Burden of gastrointestinal cancers among people younger than 50 years in China, 1990 to 2019;Public Health;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP